These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7193367)

  • 1. [Analysis and comparison of clinical staging and morphologic classification of 165 prostatic carcinomas after radical prostatectomy (author's transl)].
    Kastendieck H; Bressel M
    Urologe A; 1980 Nov; 19(6):331-9. PubMed ID: 7193367
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unexpected evidence discovered during the morphologic study of a series of 51 radical prostatectomies].
    Biedermann C; Graber P; Rist M; Mihatsch M; Chatelanat F
    Helv Chir Acta; 1982 Aug; 49(3-4):463-6. PubMed ID: 7129919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Staging of prostatic cancer before and after radical prostatectomy].
    Pushkar' DIu; Bernikov AN; Bormotin AV
    Urologiia; 2003; (4):60-8. PubMed ID: 12942732
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostication of 5-year survival in patients after radical prostatectomy].
    Al'-Shukri SKh; Borovets SIu
    Urologiia; 2005; (6):11-2. PubMed ID: 16419472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-pathologic correlation in patients undergoing surgical staging and radical prostatectomy for prostatic cancer].
    Isa Kroon WA; De Castro Barbosa F; Abad Vivas-Perez JI; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
    Actas Urol Esp; 1993 Feb; 17(2):122-5. PubMed ID: 7683170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcome and analysis of radical prostatectomy in clinical stage B and C prostate cancer].
    Miyoshi Y; Uemura H; Mikata K; Ohuchi H; Jinza S; Yao M; Takeda M; Masuda M; Noguchi S; Noguchi K; Kubota Y; Hosaka M
    Hinyokika Kiyo; 2001 Mar; 47(3):163-8. PubMed ID: 11329956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].
    van den Ouden D; Schröder FH
    Tijdschr Gerontol Geriatr; 1998 Apr; 29(2):74-9. PubMed ID: 9615377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
    J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical impact of neoadjuvant treatment to radical prostatectomy in locally advanced prostatic cancer].
    Villavicencio H; Laguna P; Ponce de Léon J
    Actas Urol Esp; 1994 May; 18 Suppl():404-8. PubMed ID: 8073926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Bastian PJ
    Eur Urol; 2009 Feb; 55(2):420. PubMed ID: 19027222
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detectable serum PSA after radical prostatectomy. Clinical and pathological relevance of perianastomotic biopsies.
    Minardi D; Galosi AB; Dell'Atti L; Yehia M; Muzzonigro G
    Anticancer Res; 2004; 24(2C):1179-85. PubMed ID: 15154644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flow cytometric examinations of patients after radical surgery for prostatic cancer].
    Romics I; Bocsi J; Bach D; Beutler W; Kopper L; Frang D
    Orv Hetil; 1995 Jun; 136(25):1323-7. PubMed ID: 7596591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
    Moul JW; Connelly RR; Perahia B; McLeod DG
    J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
    Freedland SJ; Partin AW; Epstein JI; Walsh PC
    Cancer; 2004 Apr; 100(8):1646-9. PubMed ID: 15073852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.